Intraperitoneal anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a preclinical ovarian cancer model

Vlad, Anda

Intraperitoneal anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a preclinical ovarian cancer model

Monday, March 30, 2015: 4:11 PM

Continental Ballroom (Hilton Chicago)

A. Vlad^1,2, J. Mony², L. Zhang³, T. Ma⁴, T. Tirodkar⁵, S. Grabosch⁶, J. Brozick², G. T. Tseng⁴ and R. P. Edwards¹
¹Magee-Womens Hospital of UPMC, Pittsburgh, PA, ²Magee Womens Research Institute, Pittsburgh, PA, ³Magee Womens Research Institute, ⁴University of Pittsburgh, Pittsburgh, PA, ⁵Mag, Pittsburgh, PA, ⁶Magee Womens Research Institute, Richmond Heights, PA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

Intraperitoneal anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a preclinical ovarian cancer model